Our data demonstrate that the cooperatively enhanced therapeutic effect of the combination therapy is associated with markedly enhance antigen-enhanced CD8 T cell function and sustainability in tumors, augmented DC functional potential by increasing the expression of co-stimulatory molecules CD80/86 and CD40, and enriched NK cell in tumors with enhanced anti-tumor effector function. Here, CD80 is linked to neoplasm.